0000891293-15-000059.txt : 20151120
0000891293-15-000059.hdr.sgml : 20151120
20151120173939
ACCESSION NUMBER: 0000891293-15-000059
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151119
FILED AS OF DATE: 20151120
DATE AS OF CHANGE: 20151120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIANCO LOUIS A
CENTRAL INDEX KEY: 0001204260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 151247655
MAIL ADDRESS:
STREET 1: 501 ELLIOT AVENUE WEST
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-11-19
0
0000891293
CTI BIOPHARMA CORP
ctic
0001204260
BIANCO LOUIS A
3101 WESTERN AVE
SUITE 600
SEATTLE
WA
98121
0
1
0
0
EVP, Finance & Administration
Common Stock
2015-11-19
4
S
0
800
1.1
D
920547
D
Common Stock
2015-11-19
4
S
0
1400
1.105
D
919147
D
Common Stock
2015-11-19
4
S
0
3800
1.11
D
915347
D
Common Stock
2015-11-19
4
S
0
200
1.115
D
915147
D
Common Stock
2015-11-19
4
S
0
1000
1.12
D
914147
D
Common Stock
2015-11-19
4
S
0
1000
1.125
D
913147
D
Common Stock
2015-11-19
4
S
0
1200
1.13
D
911947
D
Common Stock
2015-11-19
4
S
0
100
1.135
D
911847
D
Common Stock
2015-11-19
4
S
0
806
1.14
D
911041
D
Common Stock
2015-11-19
4
S
0
2994
1.145
D
908047
D
Common Stock
2015-11-19
4
S
0
500
1.15
D
907547
D
Common Stock
2015-11-19
4
S
0
1100
1.155
D
906447
D
Common Stock
2015-11-19
4
S
0
100
1.16
D
906347
D
Common Stock
37
I
Trust for children
The sale was effected pursuant to a Rule 10b5-1 trading plan.
Louis A. Bianco
2015-11-20